Patil, S.(2011). Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Annals of Oncology, 22(2), 295-300. doi:10.1093/annonc/mdq342